Lipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide

preview-18
  • Lipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide Book Detail

  • Author : Joel K. Kahn, MD, FACC
  • Release Date : 2020-04-10
  • Publisher : Book Publishing Company
  • Genre : Cooking
  • Pages : 160
  • ISBN 13 : 157067387X
  • File Size : 59,59 MB

Lipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide by Joel K. Kahn, MD, FACC PDF Summary

Book Description: An estimated one in five people worldwide have elevated levels of a type of cholesterol called lipoprotein(a) which can increase the risk for cardiovascular disease, including blocked arteries, blood clots, and stroke. Cardiologist Joel Kahn explains how this condition is a factor of genetics rather than poor lifestyle choices, and the best ways to test effectively for these levels. He shares research that shows plant-based diets in general provide the best defense against heart attacks, strokes, and cardiovascular disease and can play an important role in protecting individuals with elevated lipoprotein(a) levels. He has partnered with vegan expert Beverly Lynn Bennett who provides dozens of delicious oil-free, heart-healthy recipes that provide delicious options for boosting heart health.

Disclaimer: www.yourbookbest.com does not own Lipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Lipoprotein (a)

Lipoprotein (a)

File Size : 35,35 MB
Total View : 4644 Views
DOWNLOAD

Lipoprotein(a) presents the proceedings of the International Symposium, held in Chicago, Illinois, on December 2–3, 1988. It discusses the different aspects o

Lipoprotein(a)

Lipoprotein(a)

File Size : 50,50 MB
Total View : 3809 Views
DOWNLOAD

Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease. Data from case control, epige